Immune response to allogeneic equine mesenchymal stromal cells

[1] Ahmad E(2005)Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow Cytometry B Clin Cytom 67 6-12

[2] Kingma DW(2018)Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells Immunol Cell Biol 96 536-548

[3] Jaffe ES(2014)Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media PLoS ONE 9 e104662-1722

[4] Schrager JA(2016)Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints BMC Vet Res 12 65-544

[5] Janik J(2017)Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis Stem Cells Transl Med 6 1710-239

[6] Wilson W(2009)Mesenchymal stem cells suppress B-cell terminal differentiation Exp Hematol 37 604-244

[7] Stetler-Stevenson M(2020)Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility Stem Cell Res Ther 11 52-430

[8] Alagesan S(2017)Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies Equine Vet J 49 539-151

[9] Sanz-Nogués C(2013)An international serum standard for application in assays to detect human complement activation products Mol Immunol 56 232-315

[10] Chen X(2018)Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes Cytotherapy 20 232-56

[1] Ahmad E(2005)Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow Cytometry B Clin Cytom 67 6-12

[2] Kingma DW(2018)Anti-donor antibody induction following intramuscular injections of allogeneic mesenchymal stromal cells Immunol Cell Biol 96 536-548

[3] Jaffe ES(2014)Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media PLoS ONE 9 e104662-1722

[4] Schrager JA(2016)Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints BMC Vet Res 12 65-544

[5] Janik J(2017)Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis Stem Cells Transl Med 6 1710-239

[6] Wilson W(2009)Mesenchymal stem cells suppress B-cell terminal differentiation Exp Hematol 37 604-244

[7] Stetler-Stevenson M(2020)Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility Stem Cell Res Ther 11 52-430

[8] Alagesan S(2017)Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies Equine Vet J 49 539-151

[9] Sanz-Nogués C(2013)An international serum standard for application in assays to detect human complement activation products Mol Immunol 56 232-315

[10] Chen X(2018)Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes Cytotherapy 20 232-56